A 23-year-old man was referred to neuro-ophthalmology for gaze-evoked nystagmus. He had been evaluated for lower-limb incoordination due to a history of slowly progressive walking difficulty since childhood. He had asthma and eczema and no prior ophthalmic history. Magnetic resonance imaging (MRI) of his brain revealed cerebellar vermis atrophy.
On examination, visual acuities were 6/6 OU, with normal color vision and pupillary reflexes and no relative afferent pupillary defect. He had a gaze-evoked nystagmus but no oscillopsia and normal pursuit and saccades. Fundus examination revealed normal optic nerve heads with pale yellow peripapillary striae radiating from the discs predominantly following the major vascular arcades (Figure 1). The macula showed a reduced foveal reflex, and the peripheral retina was normal. Optical coherence tomography (OCT) imaging was performed, which showed significant thickening of the global peripapillary retinal nerve fiber layer (RNFL) in both eyes (right eye, 153 μm; left eye, 145 μm) and absence of the normal foveal depression (Figure 2). After genetic evaluation for ataxia at age 18 years and identification of a gene variation previously presumed to be a polymorphism, he was finally diagnosed with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Corresponding Author: Jenny L. Hepschke, BSc (Med), MBBS, DM, Birmingham Neuro-ophthalmology, Queen Elizabeth Hospital, Mindelsohn Way, Birmingham B152GW, UK (firstname.lastname@example.org).
Published Online: November 14, 2022. doi:10.1001/jamaneurol.2022.3961
Conflict of Interest Disclosures: Dr Rajabally reported receiving grants from LFB Corp and consulting fees from LFB Corp and Argenx outside the submitted work. Dr Mollan reported receiving teaching/speaker honoraria from Heidelberg Engineering, Chiesi, Allergan, Santen, Santhera, and Chugai-Roche Ltd; advisory board/consulting fees from Invex Therapeutics, Neurodiem, Janssen, and Gensight; and grants from UK Space Agency and Velux Foundation outside the submitted work. No other disclosures were reported.
Additional Contributions: We thank the patient for granting permission to publish this information.
Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.
You currently have no searches saved.
You currently have no courses saved.